President Donald Trump expects to nominate Heidi Overton as the next Food and Drug Administration (FDA) commissioner. Overton currently serves as a top aide at the White House Domestic Policy Council.
The agency has reportedly lost over 3,000 employees. This nomination arrives as the FDA faces pressure to rebuild trust within the industry and public health sectors.
Overton is a medical doctor with a doctorate in clinical investigation from Johns Hopkins University. She will lead the agency if confirmed by the Senate.
The leadership change could influence future policies and oversight for major pharmaceutical firms like Johnson & Johnson. No specific market reaction for JNJ was noted following the announcement.